Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Dig Liver Dis. 2018 Nov;50(11):1232-1237. doi: 10.1016/j.dld.2018.05.011. Epub 2018 May 23.
Relative adrenal insufficiency (RAI) has been reported in critically ill patients with cirrhosis. We evaluated the prevalence of RAI and its relationship to clinical course in non-septic cirrhosis patients with ascites.
The study included 66 consecutive non-septic cirrhosis patients with ascites. RAI was defined by a delta cortisol lower than 9 μg/dL and/or a peak cortisol lower than 18 μg/dL.
Sixty-six patients with cirrhosis and ascites were studied. The mean Child-Turcotte-Pugh (CTP) and model for end stage liver disease (MELD) scores were 10.6 ± 1.9 and 21.5 ± 7.3, respectively. The prevalence of RAI in patients with cirrhosis and ascites was 47% (31/66). The prevalence of RAI in patients with and without spontaneous bacterial peritonitis, renal failure and type 1 hepatorenal syndrome (HRS) was comparable. Baseline hyponatremia was common in RAI (42% versus 17%, p = 0.026). There was a significant correlation of prevalence of RAI with prothrombin time, international normalized ratio, MELD scores and CTP class. During follow-up, there was no association between RAI and the risk to develop new infections, severe sepsis, type 1 HRS and death.
RAI is common in non-septic cirrhotic patients with ascites and its prevalence increases with severity of liver disease. However, it does not affect the short-term outcome in these patients.
已有报道称,肝硬化危重症患者存在相对肾上腺功能不全(RAI)。我们评估了非脓毒症性肝硬化伴腹水患者中 RAI 的患病率及其与临床病程的关系。
本研究纳入了 66 例连续的非脓毒症性肝硬化伴腹水患者。RAI 定义为皮质醇差值<9μg/dL 和/或皮质醇峰值<18μg/dL。
研究纳入了 66 例肝硬化伴腹水患者。Child-Turcotte-Pugh(CTP)和终末期肝病模型(MELD)评分的平均值分别为 10.6±1.9 和 21.5±7.3。肝硬化伴腹水患者中 RAI 的患病率为 47%(31/66)。伴自发性细菌性腹膜炎、肾衰竭和 1 型肝肾综合征(HRS)的患者中 RAI 的患病率无差异。基线低钠血症在 RAI 中较为常见(42%比 17%,p=0.026)。RAI 的患病率与凝血酶原时间、国际标准化比值、MELD 评分和 CTP 分级显著相关。在随访期间,RAI 与新发感染、严重脓毒症、1 型 HRS 和死亡的风险之间无关联。
非脓毒症性肝硬化伴腹水患者中 RAI 较为常见,且其患病率随着肝病严重程度的增加而增加。然而,它并不影响这些患者的短期预后。